Legency Remedies Private Limited

Legency Remedies Private Limited, established on February 28, 2005, is a privately held pharmaceutical company headquartered in Baddi, Himachal Pradesh, India. The company is registered under the Corporate Identification Number (CIN) U24230HP2005PTC030847. As of the latest available data, Legency Remedies has an authorized capital of ₹10 million and a paid-up capital of ₹9.3 million. The company employs approximately 73 professionals. Its manufacturing facility is located at Village Katha, Tehsil Nalagarh, Baddi, Himachal Pradesh, 173205.

Legency Remedies operates a state-of-the-art manufacturing plant in Baddi, Himachal Pradesh, designed to meet global regulatory standards. The facility specializes in the production of small volume parenterals, including intravenous fluids ranging from 2ml to 50ml. It has a production capacity of one crore ampoules per month. The plant has been approved for export to countries such as Sri Lanka, Ethiopia, the Philippines, and other African nations.

The leadership team at Legency Remedies Private Limited comprises:

• Ravi Goyal – Director, appointed on August 19, 2016.
• Raman Goyal – Director, appointed on July 11, 2007.
• Manoj Kumar Jain – Director, appointed on July 11, 2007.

These directors oversee the strategic and operational aspects of the company.

Legency Remedies Private Limited has made significant strides in regulated markets, particularly in the production of respiratory solutions. The company's manufacturing facility is WHO-GMP certified, ensuring compliance with international quality standards. This certification facilitates access to markets in Sri Lanka, Ethiopia, the Philippines, and other African countries. However, specific details regarding regulatory filings, approvals, and market access in the US, EU, UK, Australia, and Japan are not publicly available.

Legency Remedies has expanded its presence in emerging markets, particularly in Africa and Southeast Asia. The WHO-GMP certification of its manufacturing facility has enabled the company to export products to countries such as Sri Lanka, Ethiopia, and the Philippines. This certification ensures that the company's products meet international quality standards, facilitating smoother market entry and acceptance.

Legency Remedies Private Limited's geographic strategy appears to be focused on expanding its footprint in emerging markets, particularly in Africa and Southeast Asia. The WHO-GMP certification of its manufacturing facility has enabled the company to export products to countries such as Sri Lanka, Ethiopia, and the Philippines. This strategic direction suggests a deliberate effort to diversify its market presence and reduce dependence on any single region.

Specific details regarding Legency Remedies Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's focus on WHO-GMP certification indicates a commitment to meeting international quality standards, which may facilitate entry into regulated markets.

Legency Remedies Private Limited's manufacturing facility is certified by the World Health Organization's Good Manufacturing Practice (WHO-GMP), ensuring compliance with international quality standards. This certification facilitates access to markets in Sri Lanka, Ethiopia, the Philippines, and other African countries. However, specific details regarding EU GMP certification or EDQM status are not publicly available.

Legency Remedies Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company's manufacturing facility is located in Baddi, Himachal Pradesh, a region known for its pharmaceutical manufacturing capabilities. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not publicly available.

As of the latest available information, there are no publicly disclosed Form 483 observations, warning letters, or import alerts associated with Legency Remedies Private Limited. The company's WHO-GMP certification indicates a commitment to maintaining high-quality manufacturing standards.

Legency Remedies Private Limited operates in the competitive pharmaceutical industry, focusing on the production of respiratory solutions and small volume parenterals. While specific competitors in overlapping categories are not publicly identified, the company's WHO-GMP certification and export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines suggest a competitive position in emerging markets.

Legency Remedies Private Limited's key differentiators include its WHO-GMP certified manufacturing facility, enabling access to regulated markets, and its focus on respiratory solutions and small volume parenterals. The company's production capacity of one crore ampoules per month and its export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines further distinguish it in the market.

Legency Remedies Private Limited's current strategic direction focuses on expanding its presence in emerging markets, particularly in Africa and Southeast Asia. The company's WHO-GMP certification and export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines support this strategy. Future outlooks may involve further diversification of its product portfolio and exploration of additional regulated markets.

Legency Remedies Private Limited demonstrates a strong track record in manufacturing and exporting pharmaceutical products. The company's WHO-GMP certified facility and production capacity of one crore ampoules per month indicate reliability and consistency in its operations. Export approvals to countries such as Sri Lanka, Ethiopia, and the Philippines further attest to the company's credibility as a supplier.

Importers should verify the following certifications when considering Legency Remedies Private Limited as a supplier:

• WHO-GMP Certification: Ensures compliance with international manufacturing standards. Verification can be obtained by contacting the company directly or through the World Health Organization's official channels.

• ISO Certifications: Indicate adherence to quality management systems. Verification can be obtained by contacting the company directly or through the International Organization for Standardization's official channels.

When conducting due diligence on Legency Remedies Private Limited, consider the following steps:

• Verify Certifications: Confirm WHO-GMP and ISO certifications through official channels.

• Assess Financial Health: Review the company's financial statements and balance sheets.

• Evaluate Manufacturing Capabilities: Assess the production capacity and quality control measures in place.

• Check Regulatory Compliance: Ensure compliance with relevant regulatory bodies in target markets.

• Review Export Approvals: Confirm export approvals to desired countries.

Be cautious of any discrepancies in certification or regulatory approvals, as these may indicate potential risks.